AIDS Research Today is a free monthly online journal that collates and summarizes the latest research about AIDS, including details on testing, treatment, prevention, hiv, life expectancy.

Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.

Shiels MS, Pfeiffer RM, Hall HI, Li J, Goedert JJ, Morton LM, Hartge P, Engels EA

Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS 7059, Rockville, MD 20892, USA. shielsms@mail.nih.gov

Published 13 April 2011 in JAMA, 305(14): 1450-9.
Full-text of this article is available online (may require subscription).

Articles on AIDS published 13 April 2011:

Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.   JAMA, 305(14): 1450-9.

[Abstract] [Full-text]

Articles on AIDS published 14 February 2011:

Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS.   J Acquir Immune Defic Syndr, 56(3): 279-84.

[Abstract] [Full-text]

Articles on AIDS published 20 December 2010:

Interactive effects of HIV/AIDS, body mass, and substance abuse on the frontal brain: a P300 study.   Psychiatry Res, 185(1): 232-7.

In view of the rising prevalence of an overweight body mass among patients living with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS), clinicians must now be mindful of possible adverse outcomes resulting from the co-occurrence. The present study was designed to examine the additive and interactive effects of HIV/AIDS and an excess body mass, as well as the additional contributions of substance abuse or dependence. The dependent variable was brain function estimated ... [Abstract] [Full-text]

Articles on AIDS published 3 December 2010:

Antibodies and lentiviruses that specifically recognize a T cell epitope derived from HIV-1 Nef protein and presented by HLA-C.   J Immunol, 185(12): 7623-32.

HIV selectively downregulates HLA-A and -B from the surfaces of infected cells to avoid detection by the immune system. In contrast, the HLA-C molecules are highly resistant to this downregulation. High expression level of HLA-C on the cell surface, which correlates with a single nucleotide polymorphism, is also associated with lower viral loads and slower progression to AIDS. These findings strongly suggest that HIV-1-derived peptides are efficiently presented by HLA-C and trigger the ... [Abstract] [Full-text]

Antibodies and lentiviruses that specifically recognize a T cell epitope derived from HIV-1 Nef protein and presented by HLA-C.   J Immunol, 185(12): 7623-32.

HIV selectively downregulates HLA-A and -B from the surfaces of infected cells to avoid detection by the immune system. In contrast, the HLA-C molecules are highly resistant to this downregulation. High expression level of HLA-C on the cell surface, which correlates with a single nucleotide polymorphism, is also associated with lower viral loads and slower progression to AIDS. These findings strongly suggest that HIV-1-derived peptides are efficiently presented by HLA-C and trigger the ... [Abstract] [Full-text]

Articles on AIDS published 2 December 2010:

Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes.   J Leukoc Biol, 88(6): 1119-30.

Several lines of evidence indicate that the interaction of HIV-1 with NK cells markedly affects host immune responses and leads to a defective control of the virus. Until recently, it was generally believed that the absolute number of total circulating NK cells was decreased during the course of chronic and active phases of HIV-1 infection and that this explained, at least in part, the defective NK cell antiviral activities. However, scientific advances made over recent years have changed this ... [Abstract] [Full-text]

Articles on AIDS published 29 November 2010:

Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.   Lancet, 376(9755): 1838-45.

[Abstract] [Full-text]

Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.   Lancet, 376(9755): 1838-45.

[Abstract] [Full-text]

© 2004-2011 AIDS Research Today. All Rights Reserved.